Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-23

Clinical Trial Update: Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

View source ↗

Summary

This report provides a pharmaco-epidemiological overview of patients treated with Aptivus (tipranavir) in real-world market use and assesses safety and efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aptivus (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED | Results posted: 2010-02-23